Vistagen Therapeutics (VTGN) Price to Sales (2012 - 2026)
Vistagen Therapeutics' (VTGN) Price to Sales came in at 4.08 for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 95.7% from 94.99 a year earlier and down 77.8% from the prior quarter.
Powered by 
Analysis
Vistagen Therapeutics (VTGN) Price to Sales (2012 - 2026) Analysis & Trends
For FY2026 (ended Mar 31, 2026), Vistagen Therapeutics' Price to Sales stood at 18.43, down 87.7% from FY2025.
- In prior fiscal years, Vistagen Therapeutics' Price to Sales was 149.99 in FY2025 (+56.2%), 96.04 in FY2024 (-23.1%), 124.85 in FY2023 (-46.0%) and 231.10 in FY2022 (-95.4%).
- The fiscal Q1 2027 figure stands as the lowest quarterly Price to Sales in data going back to fiscal Q1 2013.
- On a year-over-year basis, Price to Sales has declined in each of the last three quarters, with an average decline of 5.7% over the last eight quarters.
- The strongest year-over-year quarter for Price to Sales in the past five years was fiscal Q1 2025, with growth of 931.2%; the weakest was fiscal Q3 2022, with a decline of 96.4%.
- According to Business Quant data, Price to Sales for the three prior fiscal quarters was 18.42 (Q4 2026), 33.10 (Q3 2026) and 194.46 (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn |
| 10 | Vistagen Therapeutics | 12.43 Mn | 12.43 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.08 |
| Mar 31, 2026 | 18.42 |
| Dec 31, 2025 | 33.10 |
| Sep 30, 2025 | 194.46 |
| Jun 30, 2025 | 94.99 |
| Mar 31, 2025 | 149.99 |
| Dec 31, 2024 | 128.03 |
| Sep 30, 2024 | 99.54 |
| Jun 30, 2024 | 98.18 |
| Mar 31, 2024 | 95.06 |
| Dec 31, 2023 | 127.79 |
| Sep 30, 2023 | 61.48 |
| Jun 30, 2023 | 9.52 |
| Mar 31, 2023 | 18.18 |
| Dec 31, 2022 | 14.56 |
| Sep 30, 2022 | 19.40 |
| Jun 30, 2022 | 170.91 |
| Mar 31, 2022 | 231.10 |
| Dec 31, 2021 | 260.94 |
| Sep 30, 2021 | 360.76 |
API Access
Vistagen Therapeutics Price to Sales API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-sales&ticker=VTGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-sales", "ticker": "VTGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-sales&ticker=VTGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();